L.C. Steggink

research physician

L.C. Steggink
l.c.steggink umcg.nl


  1. Myocardial dysfunction in long-term breast cancer survivors treated at ages 40–50 years.

    Jacobse, J. N., Steggink, L., Sonke, G. S., Schaapveld, M., Hummel, Y. M., Steenbruggen, T. G., Lefrandt, J., Nuver, J., Crijns, A., Aleman, B. M. P., Gietema, J. A. & van Leeuwen, F. E., 6-Nov-2019, In : European Journal of Heart Failure.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study, Proffered paper (oral presentation) 187O

    Steenbruggen, T. G., Steggink, L., Seynaeve, C. M., van der Hoeven, JJM., Hooning, M. J., Jager, A., Konings, IR., Kroep, J. R., Smit, WM., Tjan-Heijnen, V. C. G., van der Wall, E., Bins, AD., Linn, SC., Schaapveld, M., van Leeuwen, FE., Schroder, C., van Tinteren, H., de Vries, E. G. E., Sonke, G. S. & Gietema, J. A., 2018.

    Research output: Contribution to conferenceAbstractAcademic

View all (10) »

View graph of relations

ID: 503168